|
Index of reports
> Cases resulting in hospitalization (53)
> Cases with Hypersensitivity (4)
Below is the selection of adverse event reports related to Levemir (Insulin Detemir Subcutaneous) that includes cases resulting in hospitalization where reactions include hypersensitivity.
Adverse event in receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from Turkey on 2007-07-30
Patient:
Adverse reactions / side effects: Cardio-Respiratory Arrest, Hypersensitivity, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Levemir
Dosage: 6 iu, qd
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-01-29
End date: 2007-02-08
Novorapid
Dosage: 18 iu, qd
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-01-29
End date: 2007-02-08
Other drugs received by patient: Aldactone; Lasix; Coversyl / 00790701 /; Digoxin
Adverse event in 73 year old female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from Turkey on 2007-06-26
Patient: 73 year old female, weighing 70.5 kg (155.1 pounds)
Adverse reactions / side effects: Cardio-Respiratory Arrest, Hypersensitivity, Renal Failure Acute
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Levemir
Dosage: 6 iu, qd
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-01-29
End date: 2007-02-08
Novorapid
Dosage: 18 iu, qd
Indication: Insulin-Requiring Type II Diabetes Mellitus
Start date: 2007-01-29
End date: 2007-02-08
Other drugs received by patient: Aldactone; Lasix; Coversyl / 00790701 /; Digoxin
Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from Germany on 2007-05-01
Patient: female, weighing 61.2 kg (134.6 pounds)
Adverse reactions / side effects: Hypersensitivity, Injection Site Erythema, Nausea, Restlessness, Asthenia, Tremor
Adverse event resulted in: hospitalization
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Other drugs received by patient: Insuman Basal / 00646002 /; Apidra
Adverse event in female receiving Levemir (Insulin Detemir Subcutaneous)
Reported by a physician from Germany on 2007-03-20
Patient: female, weighing 61.2 kg (134.6 pounds)
Adverse reactions / side effects: Hypersensitivity, Injection Site Erythema, Nausea, Restlessness, Asthenia, Tremor
Adverse event resulted in: hospitalization
Suspect drug(s):
Levemir (Insulin Detemir Subcutaneous)
Other drugs received by patient: Insuman Basal / 00646002 /; Apidra
|
